UnitedHealth (UNH) reported Q2 FY 2017 earnings of $2.46 per share (versus $1.96 in Q2 FY 2016), beating analysts' consensus estimate of $2.38.
The company's quarterly revenues amounted to $50.053 bln (+7.7% y/y), generally in-line with analysts' consensus estimate of $49.973 bln.
The company also improved guidance for FY 2017, projecting EPS of $9.75-9.90 compared to prior $9.65-9.85 and analysts' consensus estimate of $9.80.
UNH rose to $186.50 (+0.08%) in pre-market trading.